Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Le Quan

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
Orphanet Journal of Rare Diseases|May 25, 2019
Correction to: Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypesRobert J Pignolo, Geneviève Baujat, Matthew A Brown, et al.
European Journal of Endocrinology|November 4, 2011
Successful treatment of congenital hyperinsulinism with long-acting release octreotideKim-Hanh Le Quan Sang, Jean-Baptiste Arnoux, Asmaa Mamoune, et al.
Orphanet Journal of Rare Diseases|May 5, 2019
Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypesRobert J Pignolo, Geneviève Baujat, Matthew A Brown, et al.
Orphanet Journal of Rare Diseases|July 31, 2020
Patients with ACVR1<sup>R206H</sup> mutations have an increased prevalence of cardiac conduction abnormalities on electrocardiogram in a natural history study of Fibrodysplasia Ossificans ProgressivaSamuel Kou, Carmen De Cunto, Geneviève Baujat, et al.
Orphanet Journal of Rare Diseases|February 10, 2017
Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation studySimon A Jones, Sandra Rojas-Caro, Anthony G Quinn, et al.
Cells|November 26, 2022
Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 StudiesDaniela Braconi, Michela Geminiani, Eftychia Eirini Psarelli, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 30, 2022
Reduction of New Heterotopic Ossification (HO) in the Open-Label, Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP)Robert J Pignolo, Edward C Hsiao, Mona Al Mukaddam, et al.
The New England Journal of Medicine|July 4, 2019
C-Type Natriuretic Peptide Analogue Therapy in Children with AchondroplasiaRavi Savarirayan, Melita Irving, Carlos A Bacino, et al.
BMJ Open Gastroenterology|March 4, 2025
Vision-language large learning model, GPT4V, accurately classifies the Boston Bowel Preparation Scale scoreDaniel Yan Zheng Lim, Yu Bin Tan, Jonas Ren Yi Ho, et al.
Journal of Medical Genetics|January 23, 2013
Asphyxiating thoracic dysplasia: clinical and molecular review of 39 familiesGeneviève Baujat, Céline Huber, Joyce El Hokayem, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Orphanet Journal of Rare Diseases|May 25, 2019
Correction to: Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypesRobert J Pignolo, Geneviève Baujat, Matthew A Brown, et al.
European Journal of Endocrinology|November 4, 2011
Successful treatment of congenital hyperinsulinism with long-acting release octreotideKim-Hanh Le Quan Sang, Jean-Baptiste Arnoux, Asmaa Mamoune, et al.
Orphanet Journal of Rare Diseases|May 5, 2019
Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypesRobert J Pignolo, Geneviève Baujat, Matthew A Brown, et al.
Orphanet Journal of Rare Diseases|July 31, 2020
Patients with ACVR1<sup>R206H</sup> mutations have an increased prevalence of cardiac conduction abnormalities on electrocardiogram in a natural history study of Fibrodysplasia Ossificans ProgressivaSamuel Kou, Carmen De Cunto, Geneviève Baujat, et al.
Orphanet Journal of Rare Diseases|February 10, 2017
Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation studySimon A Jones, Sandra Rojas-Caro, Anthony G Quinn, et al.
Cells|November 26, 2022
Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 StudiesDaniela Braconi, Michela Geminiani, Eftychia Eirini Psarelli, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 30, 2022
Reduction of New Heterotopic Ossification (HO) in the Open-Label, Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP)Robert J Pignolo, Edward C Hsiao, Mona Al Mukaddam, et al.
The New England Journal of Medicine|July 4, 2019
C-Type Natriuretic Peptide Analogue Therapy in Children with AchondroplasiaRavi Savarirayan, Melita Irving, Carlos A Bacino, et al.
BMJ Open Gastroenterology|March 4, 2025
Vision-language large learning model, GPT4V, accurately classifies the Boston Bowel Preparation Scale scoreDaniel Yan Zheng Lim, Yu Bin Tan, Jonas Ren Yi Ho, et al.
Journal of Medical Genetics|January 23, 2013
Asphyxiating thoracic dysplasia: clinical and molecular review of 39 familiesGeneviève Baujat, Céline Huber, Joyce El Hokayem, et al.
Pageof 13